PURPOSE: 4-[(18)F]-ADAM is a potent serotonin transport imaging agent. We studied its toxicity in rats and radiation dosimetry in monkeys before human studies are undertaken. METHODS: Single and multiple-dosage toxicity studies were conducted in Sprague-Dawley rats. Male and female rats were injected intravenously with 4-F-ADAM as a single dose of 1,023.7 microg/kg (1,000 times the human dose) or as five consecutive daily doses of 102.37 microg/kg (100 times the human dose). PET/CT scans were performed in seven Formosa Rock monkeys (four males and three females) using a Siemens Biograph scanner. After injection of 4-[(18)F]-ADAM (182+/-8 MBq), a low dose CT scan and a series of eight whole-body PET scans were performed. Whole-body images were acquired in 3-D mode. Time-activity data of source organs were used to calculate the residence times and estimate the absorbed radiation dose using OLINDA/EXM software. RESULTS: In the rats neither the single dose nor the five daily doses of 4-F-ADAM produced overt adverse effects clinically. In the monkeys the radiation doses received by most organs ranged between 7.1 and 35.7 microGy/MBq, and the urinary bladder was considered to be the critical organ. The effective doses extrapolated to male and female adult humans were 17.4 and 21.8 microSv/MBq, respectively. CONCLUSION: Toxicity studies in Sprague-Dawley rats and radiation dosimetry studies in Formosa Rock monkeys suggested that 4-[(18)F]-ADAM is safe for use in human PET imaging studies.
PURPOSE: 4-[(18)F]-ADAM is a potent serotonin transport imaging agent. We studied its toxicity in rats and radiation dosimetry in monkeys before human studies are undertaken. METHODS: Single and multiple-dosage toxicity studies were conducted in Sprague-Dawley rats. Male and female rats were injected intravenously with 4-F-ADAM as a single dose of 1,023.7 microg/kg (1,000 times the human dose) or as five consecutive daily doses of 102.37 microg/kg (100 times the human dose). PET/CT scans were performed in seven Formosa Rock monkeys (four males and three females) using a Siemens Biograph scanner. After injection of 4-[(18)F]-ADAM (182+/-8 MBq), a low dose CT scan and a series of eight whole-body PET scans were performed. Whole-body images were acquired in 3-D mode. Time-activity data of source organs were used to calculate the residence times and estimate the absorbed radiation dose using OLINDA/EXM software. RESULTS: In the rats neither the single dose nor the five daily doses of 4-F-ADAM produced overt adverse effects clinically. In the monkeys the radiation doses received by most organs ranged between 7.1 and 35.7 microGy/MBq, and the urinary bladder was considered to be the critical organ. The effective doses extrapolated to male and female adult humans were 17.4 and 21.8 microSv/MBq, respectively. CONCLUSION:Toxicity studies in Sprague-Dawley rats and radiation dosimetry studies in Formosa Rock monkeys suggested that 4-[(18)F]-ADAM is safe for use in human PET imaging studies.
Authors: Dnyanesh N Tipre; Masahiro Fujita; Frederick T Chin; Nicholas Seneca; Douglas Vines; Jeih-San Liow; Victor W Pike; Robert B Innis Journal: Nucl Med Commun Date: 2004-07 Impact factor: 1.690
Authors: Marie-José Bélanger; Norman R Simpson; Theodore Wang; Ronald L Van Heertum; J John Mann; Ramin V Parsey Journal: Nucl Med Biol Date: 2004-11 Impact factor: 2.408
Authors: S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely Journal: Proc Natl Acad Sci U S A Date: 1993-03-15 Impact factor: 11.205
Authors: Swen Hesse; Peter Brust; Peter Mäding; Georg-Alexander Becker; Marianne Patt; Anita Seese; Dietlind Sorger; Jörg Zessin; Philipp M Meyer; Donald Lobsien; Sven Laudi; Bernd Habermann; Frank Füchtner; Julia Luthardt; Anke Bresch; Jörg Steinbach; Osama Sabri Journal: Eur J Nucl Med Mol Imaging Date: 2012-02-17 Impact factor: 9.236
Authors: Dangshe Ma; Jessica R Kirshner; Richard Tavaré; Makenzie Danton; Jason T Giurleo; Sosina Makonnen; Carlos Hickey; Tomas C Arnold; Marcus P Kelly; Fanny Fredriksson; Karina Bruestle; Aynur Hermann; Erica Ullman; Kurt H Edelmann; Terra Potocky; Drew Dudgeon; Nikunj B Bhatt; Mikhail Doubrovin; Thomas Barry; Christos A Kyratsous; Cagan Gurer; Naxin Tu; Hans Gartner; Andrew Murphy; Lynn E Macdonald; Jon Popke; Akiva Mintz; Adam Griesemer; William C Olson; Gavin Thurston Journal: Cancer Immunol Res Date: 2022-10-04 Impact factor: 12.020
Authors: Nikolaos Dimitrakakis; Anna Waterhouse; Shanda Lightbown; Daniel C Leslie; Amanda Jiang; Dana E Bolgen; Kayla Lightbown; Kelly Cascio; Gabriela Aviles; Elizabeth Pollack; Sam Jurek; Kathryn Donovan; Julia B Hicks-Berthet; Kazuo Imaizumi; Michael Super; Donald E Ingber; Arthur Nedder Journal: J Am Assoc Lab Anim Sci Date: 2021-12-13 Impact factor: 1.706
Authors: Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen Journal: Med Res Rev Date: 2011-06-14 Impact factor: 12.944